Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Termination of Ultragenyx’s UX053 Phase I/II study is a minor setback for mRNA therapeutics:…
UX053 was one of five non-vaccine mRNA therapeutics in clinical trial development. The other four are all currently in Phase I/II…
LANXESS expands Lewatit range
New Lewatit ion exchange resins and adsorbers for separation, purification, and chromatography of biomolecules
Emcure Pharma launches 750 mg injectable variant of Ferric Carboxymaltose
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
In April 2023, the healthcare industry reported 62 deals worth $22.7 bn: GlobalData
VC investments decreased by 45.8 per cent in April 2023, compared to April 2022
US FDA audit at Hikal’s Panoli facility concludes with zero observations
The five-day preapproval inspection of an API was conducted from May 8-12, 2023
BioNTech, Roche’s pancreatic cancer treatment bodes well for future: Nature
Half of the trial participants had developed T cells that can potentially recognise cancerous cells and stop them from re-emerging
Otsuka Pharma gets USFDA approval for Brexpiprazole to treat Alzheimer’s agitation
Brexpiprazole was previously approved in the US to treat adults with major depressive disorder and schizophrenia
Glenmark Foundation concludes fifth season of ‘Meri Poushtik Rasoi’ National Cooking…
As a pan-India initiative, it aimed at addressing the issue of malnutrition through the promotion of nutrition-rich native recipes
TechInvention launches Euvichol-Plus, oral cholera vaccine in India
Euvichol-Plus is a WHO prequalified vaccine launched in a low-density polyethylene (LDPE) unidose pack
IT dept raids premises of Mankind Pharma over allegations of tax evasion
Sources revealed that the department is searching the premises in Delhi and nearby locations, documents are being checked and…